Salvador Macip is a professor of molecular medicine at the University of Leicester, which he joined in 2008, and has also been a professor and director of the Faculty of Health Sciences at Universitat Oberta de Catalunya since 2022. He leads the Mechanisms of Cancer and Ageing Lab, with sites at the University of Leicester (UK) and the Josep Carreras Institute (Spain). Since earning a degree in medicine in 1994 and a Ph.D. in molecular genetics and human physiology in 1998 from the University of Barcelona, he has devoted his career to the study of cancer and aging at prestigious institutions such as Mount Sinai Hospital in New York. In his laboratory work, he studies the cellular and molecular bases of aging, particularly senescence, and proposes strategies that could impact this phenotype, ranging from nanotechnology to nutritional manipulation, with the aim of applying them in pre-clinical in vivo studies. He also studies the response of B-cell leukemias to current treatments in order to determine how and why resistance appears and to propose alternative treatments (drug combinations, personalized treatments, etc.) that could be more effective.
